logy & Oncology 1. E-CEL Stem-Cell Gene Therapy • Goal: Cure genetic blood diseases(e.g., Sickle Cell Anemia) • Clinical stage: H2 2017 (1" trial, Leukemia with high-risk genetic characteristics) e199R1I'M 2. E-CEL Cellular Therapy • Goal: Accelerate recovery from radiation/chemotherapy • Clinical s

eveloping non-Hodgkin lymphoma, a blood cancer that starts in cells called lymphocytes, which are part of the body's immune system. According to the Leukemia and Lymphoma Society, there is a higher reported incidence of non-Hodgkin lymphoma in farming communities. And that a number of studies (including

ulations to Related's Team in Training Cycling Team<=:p> Congratulations to Related's Team in Training =ycling Team for fund raising $31,662 for the Leukemia and Lymphoma Society= Over the past 4 months, the team has been fundraising and training =o complete Team in Training's premier event, America's Mo

biopsy procedure, however, can be very difficult for a patient, especially if the tumor is in the bone, and is not possible for all cancers such as Leukemia, when tumors rarely form. Furthermore, a biopsy cannot EFTA_R1_02139795 EFTA02714314 keep up to date with rapidly evolving mutations and rarely r